ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,687,000 | -97.2% | 585,890 | -95.7% | 0.14% | -97.5% |
| Q3 2017 | $61,213,000 | -2.2% | 13,633,220 | 0.0% | 5.53% | -23.0% |
| Q2 2017 | $62,576,000 | +9.0% | 13,633,220 | 0.0% | 7.18% | +2.0% |
| Q1 2017 | $57,396,000 | +1.9% | 13,633,220 | 0.0% | 7.04% | -11.7% |
| Q4 2016 | $56,305,000 | -42.2% | 13,633,220 | +13.3% | 7.98% | -20.7% |
| Q3 2016 | $97,469,000 | +3.8% | 12,033,220 | 0.0% | 10.06% | -22.6% |
| Q2 2016 | $93,859,000 | +1.0% | 12,033,220 | 0.0% | 13.00% | +9.4% |
| Q1 2016 | $92,896,000 | -23.3% | 12,033,220 | +7.2% | 11.87% | -0.9% |
| Q4 2015 | $121,095,000 | +49.4% | 11,222,893 | -4.4% | 11.98% | +2.9% |
| Q3 2015 | $81,081,000 | -8.0% | 11,733,815 | +18.0% | 11.64% | +31.4% |
| Q2 2015 | $88,122,000 | +8.9% | 9,945,997 | +21.2% | 8.86% | +10.3% |
| Q1 2015 | $80,926,000 | -28.2% | 8,207,530 | -10.8% | 8.04% | -33.6% |
| Q4 2014 | $112,700,000 | +16.4% | 9,200,000 | -5.2% | 12.11% | +5.9% |
| Q3 2014 | $96,806,000 | -49.8% | 9,700,000 | -61.9% | 11.44% | -41.3% |
| Q2 2014 | $192,929,000 | +122.4% | 25,486,007 | -3.3% | 19.50% | +213.5% |
| Q1 2014 | $86,744,000 | -0.9% | 26,366,007 | 0.0% | 6.22% | -39.0% |
| Q4 2013 | $87,509,000 | +45.2% | 26,366,007 | +32.1% | 10.19% | +62.0% |
| Q3 2013 | $60,270,000 | -22.1% | 19,957,061 | +111.1% | 6.29% | -38.7% |
| Q2 2013 | $77,344,000 | – | 9,455,202 | – | 10.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $66,866,000 | 7.90% |
| RA Capital Management | 3,000,000 | $29,940,000 | 3.54% |
| Camber Capital Management LP | 3,250,000 | $32,435,000 | 3.05% |
| DOHENY ASSET MANAGEMENT /CA | 542,325 | $5,412,000 | 2.71% |
| QVT Financial LP | 2,504,677 | $24,997,000 | 1.29% |
| Atika Capital Management LLC | 123,700 | $1,235,000 | 0.95% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,996,000 | 0.58% |
| Bain Capital Public Equity Management, LLC | 2,246,632 | $22,421,000 | 0.58% |
| BB BIOTECH AG | 1,279,340 | $12,768,000 | 0.52% |
| EAM Investors, LLC | 222,842 | $2,224,000 | 0.45% |